Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289792933> ?p ?o ?g. }
- W4289792933 endingPage "6876" @default.
- W4289792933 startingPage "6866" @default.
- W4289792933 abstract "Immune checkpoint blockade (ICB) therapy has revolutionized clinical oncology. However, the efficacy of ICB therapy is limited by the ineffective infiltration of T effector (Teff) cells to tumors and the immunosuppressive tumor microenvironment (TME). Here, we report a programmable tumor cells/Teff cells bispecific nano-immunoengager (NIE) that can circumvent these limitations to improve ICB therapy. The peptidic nanoparticles (NIE-NPs) bind tumor cell surface α3β1 integrin and undergo in situ transformation into nanofibrillar network nanofibers (NIE-NFs). The prolonged retained nanofibrillar network at the TME captures Teff cells via the activatable α4β1 integrin ligand and allows sustained release of resiquimod for immunomodulation. This bispecific NIE eliminates syngeneic 4T1 breast cancer and Lewis lung cancer models in mice, when given together with anti-PD-1 antibody. The in vivo structural transformation-based supramolecular bispecific NIE represents an innovative class of programmable receptor-mediated targeted immunotherapeutics to greatly enhance ICB therapy against cancers." @default.
- W4289792933 created "2022-08-04" @default.
- W4289792933 creator A5000073737 @default.
- W4289792933 creator A5002480954 @default.
- W4289792933 creator A5015305941 @default.
- W4289792933 creator A5016566536 @default.
- W4289792933 creator A5017220491 @default.
- W4289792933 creator A5022755556 @default.
- W4289792933 creator A5024091430 @default.
- W4289792933 creator A5031378783 @default.
- W4289792933 creator A5034418338 @default.
- W4289792933 creator A5034524175 @default.
- W4289792933 creator A5044757881 @default.
- W4289792933 creator A5051904305 @default.
- W4289792933 creator A5055245426 @default.
- W4289792933 creator A5057416382 @default.
- W4289792933 creator A5058384978 @default.
- W4289792933 creator A5058606592 @default.
- W4289792933 creator A5062802999 @default.
- W4289792933 creator A5065066504 @default.
- W4289792933 creator A5067184921 @default.
- W4289792933 creator A5070013455 @default.
- W4289792933 creator A5076817185 @default.
- W4289792933 creator A5077305192 @default.
- W4289792933 creator A5079804769 @default.
- W4289792933 creator A5087154304 @default.
- W4289792933 date "2022-08-04" @default.
- W4289792933 modified "2023-10-18" @default.
- W4289792933 title "Programmable Bispecific Nano-immunoengager That Captures T Cells and Reprograms Tumor Microenvironment" @default.
- W4289792933 cites W1968583232 @default.
- W4289792933 cites W1983902360 @default.
- W4289792933 cites W1992181634 @default.
- W4289792933 cites W2000846699 @default.
- W4289792933 cites W2036094153 @default.
- W4289792933 cites W2059861908 @default.
- W4289792933 cites W2060070314 @default.
- W4289792933 cites W2066671159 @default.
- W4289792933 cites W2144733364 @default.
- W4289792933 cites W2166386800 @default.
- W4289792933 cites W2292733418 @default.
- W4289792933 cites W2340636398 @default.
- W4289792933 cites W2554773181 @default.
- W4289792933 cites W2560367415 @default.
- W4289792933 cites W2588186041 @default.
- W4289792933 cites W2599210471 @default.
- W4289792933 cites W2739636520 @default.
- W4289792933 cites W2783137027 @default.
- W4289792933 cites W2788206402 @default.
- W4289792933 cites W2791931250 @default.
- W4289792933 cites W2799316847 @default.
- W4289792933 cites W2800477374 @default.
- W4289792933 cites W2802936104 @default.
- W4289792933 cites W2897707709 @default.
- W4289792933 cites W2899227578 @default.
- W4289792933 cites W2909301717 @default.
- W4289792933 cites W2942224185 @default.
- W4289792933 cites W2945529787 @default.
- W4289792933 cites W2946126594 @default.
- W4289792933 cites W2953307605 @default.
- W4289792933 cites W2962717330 @default.
- W4289792933 cites W2986868963 @default.
- W4289792933 cites W3001026887 @default.
- W4289792933 cites W3004469538 @default.
- W4289792933 cites W3020879277 @default.
- W4289792933 cites W3029378003 @default.
- W4289792933 cites W3030881897 @default.
- W4289792933 cites W4239552383 @default.
- W4289792933 doi "https://doi.org/10.1021/acs.nanolett.2c00582" @default.
- W4289792933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35926215" @default.
- W4289792933 hasPublicationYear "2022" @default.
- W4289792933 type Work @default.
- W4289792933 citedByCount "1" @default.
- W4289792933 countsByYear W42897929332023 @default.
- W4289792933 crossrefType "journal-article" @default.
- W4289792933 hasAuthorship W4289792933A5000073737 @default.
- W4289792933 hasAuthorship W4289792933A5002480954 @default.
- W4289792933 hasAuthorship W4289792933A5015305941 @default.
- W4289792933 hasAuthorship W4289792933A5016566536 @default.
- W4289792933 hasAuthorship W4289792933A5017220491 @default.
- W4289792933 hasAuthorship W4289792933A5022755556 @default.
- W4289792933 hasAuthorship W4289792933A5024091430 @default.
- W4289792933 hasAuthorship W4289792933A5031378783 @default.
- W4289792933 hasAuthorship W4289792933A5034418338 @default.
- W4289792933 hasAuthorship W4289792933A5034524175 @default.
- W4289792933 hasAuthorship W4289792933A5044757881 @default.
- W4289792933 hasAuthorship W4289792933A5051904305 @default.
- W4289792933 hasAuthorship W4289792933A5055245426 @default.
- W4289792933 hasAuthorship W4289792933A5057416382 @default.
- W4289792933 hasAuthorship W4289792933A5058384978 @default.
- W4289792933 hasAuthorship W4289792933A5058606592 @default.
- W4289792933 hasAuthorship W4289792933A5062802999 @default.
- W4289792933 hasAuthorship W4289792933A5065066504 @default.
- W4289792933 hasAuthorship W4289792933A5067184921 @default.
- W4289792933 hasAuthorship W4289792933A5070013455 @default.
- W4289792933 hasAuthorship W4289792933A5076817185 @default.
- W4289792933 hasAuthorship W4289792933A5077305192 @default.
- W4289792933 hasAuthorship W4289792933A5079804769 @default.
- W4289792933 hasAuthorship W4289792933A5087154304 @default.